{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:59:37Z","timestamp":1778579977105,"version":"3.51.4"},"reference-count":40,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T00:00:00Z","timestamp":1335916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Adherence to antiretroviral therapy (<jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>) among injecting drug users (<jats:styled-content style=\"fixed-case\">IDUs<\/jats:styled-content>) is often suboptimal, yet little is known about changes in patterns of adherence since the advent of highly active antiretroviral therapy in 1996. We sought to assess levels of optimal adherence to <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> among <jats:styled-content style=\"fixed-case\">IDUs<\/jats:styled-content> in a setting of free and universal <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were collected through a prospective cohort study of <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive <jats:styled-content style=\"fixed-case\">IDUs<\/jats:styled-content> in Vancouver, British Columbia. We calculated the proportion of individuals achieving at least 95% adherence in the year following initiation of <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> from 1996 to 2009.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 682 individuals who initiated <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>, the median age was 37 years (interquartile range 31\u201344 years) and 248 participants (36.4%) were female. The proportion achieving at least 95% adherence increased over time, from 19.3% in 1996 to 65.9% in 2009 (Cochrane\u2013Armitage test for trend: <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). In a logistic regression model examining factors associated with 95% adherence, initiation year was statistically significant (odds ratio 1.08; 95% confidence interval 1.03\u20131.13; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001 per year after 1996) after adjustment for a range of drug use variables and other potential confounders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The proportion of <jats:styled-content style=\"fixed-case\">IDUs<\/jats:styled-content> achieving at least 95% adherence during the first year of <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> has consistently increased over a 13\u2010year period. Although improved tolerability and convenience of modern <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> regimens probably explain these positive trends, by the end of the study period a substantial proportion of <jats:styled-content style=\"fixed-case\">IDUs<\/jats:styled-content> still had suboptimal adherence, demonstrating the need for additional adherence support strategies.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2012.01021.x","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T03:13:41Z","timestamp":1336014821000},"page":"596-601","source":"Crossref","is-referenced-by-count":19,"title":["Improved adherence to modern antiretroviral therapy among <scp>HIV<\/scp>\u2010infected injecting drug users"],"prefix":"10.1111","volume":"13","author":[{"given":"B","family":"Mann","sequence":"first","affiliation":[{"name":"Department of Medicine University of Calgary  Calgary AB Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u2010J","family":"Milloy","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS St Paul's Hospital  Vancouver BC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Kerr","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS St Paul's Hospital  Vancouver BC Canada"},{"name":"Department of Medicine University of British Columbia  Vancouver BC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Zhang","sequence":"additional","affiliation":[{"name":"Provincial Health Services Authority  Vancouver BC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Montaner","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS St Paul's Hospital  Vancouver BC Canada"},{"name":"Department of Medicine University of British Columbia  Vancouver BC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Wood","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS St Paul's Hospital  Vancouver BC Canada"},{"name":"Department of Medicine University of British Columbia  Vancouver BC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,5,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610103351501"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709113371101"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1086\/378703"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2007.03.009"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.91.7.1060"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61311-2"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-1-200007040-00004"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15022-2"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1081\/ADA-100100600"},{"key":"e_1_2_6_11_1","first-page":"407","article-title":"Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver","volume":"9","author":"Kerr T","year":"2004","journal-title":"AVT"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-005-9041-y"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31815767d6"},{"key":"e_1_2_6_14_1","first-page":"1","article-title":"Failure to maintain adherence to HAART in a cohort of French HIV\u2010positive injecting drug users","volume":"10","author":"Carrieri MP","year":"2003","journal-title":"IJBM"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1097\/00002030-199909100-00021","article-title":"Soriano V and Gonzalez\u2010Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy","volume":"13","author":"Gordillo V","year":"1999","journal-title":"AIDS"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.02.003"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.6.547"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-10-200311180-00008"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.5.550"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200205030-00012"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200003310-00005"},{"key":"e_1_2_6_22_1","first-page":"656","article-title":"Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV\u20101 infected injection drug users","volume":"169","author":"Wood E","year":"2003","journal-title":"CMAJ"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200102160-00021"},{"key":"e_1_2_6_24_1","first-page":"360","article-title":"Adherence to triple therapy and viral load response","volume":"23","author":"Low\u2010Beer S","year":"2000","journal-title":"JAIDS"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200205030-00012"},{"key":"e_1_2_6_26_1","volume-title":"World Health Organization, Child and Adolescent Health","author":"WHO","year":"2011"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-10-200311180-00008"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116813"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2008.12.043"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir032"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200212153-00013"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.6.544"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1086\/313849"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-011-9942-x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-008-9489-7"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S22771"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2009.0024"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2005.00287.x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1614"},{"key":"e_1_2_6_40_1","first-page":"360","article-title":"Adherence to triple therapy and viral load response","volume":"23","author":"Low\u2010Beer S","year":"2000","journal-title":"JAIDS"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02269.x"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2012.01021.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2012.01021.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T00:52:15Z","timestamp":1695516735000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2012.01021.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,2]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1111\/j.1468-1293.2012.01021.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2012.01021.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,2]]}}}